Always follow the missed-dose directions in your Medication Guide or ask your healthcare provider or pharmacist what to do
2018 study found that adults taking Semaglutide experienced significant weight loss and improved glucose control
The subcutaneous layer may be less uniform, with areas of tissue thinning alternating with areas of normal thickness
Recent dose increases, active nausea or vomiting, severe appetite suppression, low hemoglobin, hypotension, dehydration, or concurrent weight loss exceeding 2 pounds weekly all suggest postponing donation until stability improves
No human DDI data exist for these combinations
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 [Internet]